Amarin Corp Plc (AMRN)

[Pharmacydude]

Kiwi
“Note. “This study suggests that early aspirin use may be associated with lower odds of in-hospital mortality among hospitalized patients with moderate COVID-19”

This is also interesting because aspirin interacts with the COX-2 receptor in the endothelium leading to increased production of E Series Resolvins.

What if the cardio protective actions of ASA are the result of increased E Series Resolvins and not (just) anti platelet actions???

A review of the R-it data comparing ASA/EPA efficacy vs EPA alone would be interesting.

https://drive.google.com/file/d/1Fw3UqjnX40X7Voy8GnhzyrUVNVRz9DfJ/view?usp=drivesdk